Tourmaline Bio, Inc (TRML) insider trading
Every open-market stock purchase and sale by Tourmaline Bio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Sandeep Chidambar Kulkarni (CEO), $26.4K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent TRML insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 28, 2025 | Sandeep Chidambar Kulkarni (CEO) | Sold (not open market) | $4M |
| Oct 28, 2025 | Sandeep Chidambar Kulkarni (CEO) | Sold (not open market) | $3.5M |
| Oct 28, 2025 | Sandeep Chidambar Kulkarni (CEO) | Sold (not open market) | $2.4M |
| Oct 28, 2025 | Ryan F. Robinson (CFO) | Sold (not open market) | $1.1M |
| Oct 28, 2025 | W Bradford Middlekauff (C-suite exec) | Sold (not open market) | $987K |
| Oct 28, 2025 | W Bradford Middlekauff (C-suite exec) | Sold (not open market) | $986K |
| Oct 28, 2025 | Kevin Bruce Johnson (C-suite exec) | Sold (not open market) | $986K |
| Oct 28, 2025 | Susan Dana Jones (CTO) | Sold (not open market) | $986K |
| Oct 28, 2025 | Ryan F. Robinson (CFO) | Sold (not open market) | $986K |
| Oct 28, 2025 | Kevin Bruce Johnson (C-suite exec) | Sold (not open market) | $760K |
| Oct 28, 2025 | Susan Dana Jones (CTO) | Sold (not open market) | $602K |
| Oct 28, 2025 | Susan Dana Jones (CTO) | Sold (not open market) | $442K |
| Oct 28, 2025 | Kevin Bruce Johnson (C-suite exec) | Sold (not open market) | $442K |
| Oct 28, 2025 | W Bradford Middlekauff (C-suite exec) | Sold (not open market) | $442K |
| Oct 28, 2025 | Clay B Siegall (Insider) | Sold (not open market) | $371K |
| Oct 28, 2025 | Ryan F. Robinson (CFO) | Sold (not open market) | $360K |
| Oct 28, 2025 | Aaron Kantoff (Insider) | Sold (not open market) | $315K |
| Oct 28, 2025 | Mark McDade (Insider) | Sold (not open market) | $315K |
| Oct 28, 2025 | Caley Castelein (Insider) | Sold (not open market) | $315K |
| Oct 28, 2025 | Parvinder Thiara (Insider) | Sold (not open market) | $315K |
| Oct 28, 2025 | Clay B Siegall (Insider) | Sold (not open market) | $315K |
| Oct 28, 2025 | Sapna Srivastava (Insider) | Sold (not open market) | $315K |
| Oct 28, 2025 | Clay B Siegall (Insider) | Sold (not open market) | $209K |
| Oct 28, 2025 | Sapna Srivastava (Insider) | Sold (not open market) | $189K |
| Oct 28, 2025 | Mark McDade (Insider) | Sold (not open market) | $189K |
Who's trading TRML
- Parvinder Thiara, Director: other filings, last Oct 28, 2025
- Caley Castelein, Director: other filings, last Oct 28, 2025
- Kevin Bruce Johnson, C-suite exec: other filings, last Oct 28, 2025
- Susan Dana Jones, CTO: other filings, last Oct 28, 2025
- Aaron Kantoff, Director: other filings, last Oct 28, 2025
- Sandeep Chidambar Kulkarni, CEO: other filings, last Oct 28, 2025
- Mark McDade, Insider: other filings, last Oct 28, 2025
- W Bradford Middlekauff, C-suite exec: other filings, last Oct 28, 2025
- Ryan F. Robinson, CFO: other filings, last Oct 28, 2025
- Clay B Siegall, Director: other filings, last Oct 28, 2025
- Sapna Srivastava, Director: other filings, last Oct 28, 2025
Get free alerts when an insider at Tourmaline Bio, Inc files a new trade →